0 XP   0   0   0

Pharmacielo Ltd
Buy or Sell?

Welcome Invester! I guess you are interested in Pharmacielo Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Pharmacielo Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Pharmacielo Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Pharmacielo Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Pharmacielo Ltd. The closing price on 2022-09-28 was $0.3098 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Pharmacielo Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Pharmacielo Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Pharmacielo generates for each $1 of revenue.

  • Above 10% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Net Profit Margin of -856.6% means that $-8.57 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pharmacielo Ltd:

  • The MRQ is -166.0%. The company is making a huge loss. -2
  • The TTM is -856.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-166.0%TTM-856.6%+690.7%
TTM-856.6%YOY-7,213.6%+6,357.0%
TTM-856.6%5Y-2,604.5%+1,747.9%
5Y-2,604.5%10Y-2,604.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-166.0%0.9%-166.9%
TTM-856.6%1.1%-857.7%
YOY-7,213.6%1.7%-7,215.3%
5Y-2,604.5%0.8%-2,605.3%
10Y-2,604.5%1.3%-2,605.8%
1.1.2. Return on Assets

Shows how efficient Pharmacielo is using its assets to generate profit.

  • Above 5% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • -13.8% Return on Assets means that Pharmacielo generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pharmacielo Ltd:

  • The MRQ is -11.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -13.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.7%TTM-13.8%+2.2%
TTM-13.8%YOY-25.6%+11.7%
TTM-13.8%5Y-16.9%+3.0%
5Y-16.9%10Y-16.9%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.7%0.2%-11.9%
TTM-13.8%0.2%-14.0%
YOY-25.6%0.1%-25.7%
5Y-16.9%-0.1%-16.8%
10Y-16.9%0.2%-17.1%
1.1.3. Return on Equity

Shows how efficient Pharmacielo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • -24.9% Return on Equity means the company generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pharmacielo Ltd:

  • The MRQ is -24.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.9%TTM-25.1%+0.2%
TTM-25.1%YOY-41.0%+15.9%
TTM-25.1%5Y-24.7%-0.3%
5Y-24.7%10Y-24.7%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.9%0.8%-25.7%
TTM-25.1%0.6%-25.7%
YOY-41.0%0.6%-41.6%
5Y-24.7%0.1%-24.8%
10Y-24.7%0.5%-25.2%

1.2. Operating Efficiency of Pharmacielo Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pharmacielo is operating (creating products, providing services etc).

  • Measures how much profit Pharmacielo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operating Margin of -139.0% means the company generated $-1.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pharmacielo Ltd:

  • The MRQ is -139.0%. The company is operating very inefficient. -2
  • The TTM is -783.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-139.0%TTM-783.4%+644.4%
TTM-783.4%YOY-10,422.9%+9,639.5%
TTM-783.4%5Y-3,406.5%+2,623.1%
5Y-3,406.5%10Y-3,406.5%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-139.0%3.9%-142.9%
TTM-783.4%2.3%-785.7%
YOY-10,422.9%3.9%-10,426.8%
5Y-3,406.5%3.6%-3,410.1%
10Y-3,406.5%1.9%-3,408.4%
1.2.2. Operating Ratio

Measures how efficient Pharmacielo is keeping operating costs (creating products, providing services etc) low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 299.6% means that the operating costs are $3.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pharmacielo Ltd:

  • The MRQ is 2.996. The company is inefficient in keeping operating costs low. -1
  • The TTM is 10.849. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.996TTM10.849-7.852
TTM10.849YOY89.123-78.274
TTM10.8495Y30.888-20.040
5Y30.88810Y30.8880.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9961.488+1.508
TTM10.8491.439+9.410
YOY89.1231.382+87.741
5Y30.8881.363+29.525
10Y30.8881.160+29.728

1.3. Liquidity of Pharmacielo Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pharmacielo is able to pay off short-term debts (debts due within 1 year) when selling its assets.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 80.9% means the company has $0.81 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pharmacielo Ltd:

  • The MRQ is 0.809. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.922. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.809TTM0.922-0.114
TTM0.922YOY1.267-0.345
TTM0.9225Y4.429-3.507
5Y4.42910Y4.4290.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8091.884-1.075
TTM0.9221.898-0.976
YOY1.2672.092-0.825
5Y4.4292.123+2.306
10Y4.4291.833+2.596
1.3.2. Quick Ratio

Measures if Pharmacielo is able to pay off short-term debts (debts due within 1 year). But only using the most liquid assets (assets that can be quickly converted to cash).

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 120.3% means the company can pay off $1.20 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pharmacielo Ltd:

  • The MRQ is 1.203. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.376. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.203TTM0.376+0.827
TTM0.376YOY0.213+0.163
TTM0.3765Y1.225-0.849
5Y1.22510Y1.2250.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2030.636+0.567
TTM0.3760.780-0.404
YOY0.2130.805-0.592
5Y1.2250.833+0.392
10Y1.2250.824+0.401

1.4. Solvency of Pharmacielo Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pharmacielo assets are financed with debt

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.53 means that Pharmacielo assets are financed with 53.0% credit (debt) and the remaining percentage (100% - 53.0%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Pharmacielo Ltd:

  • The MRQ is 0.530. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.458. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.530TTM0.458+0.073
TTM0.458YOY0.329+0.128
TTM0.4585Y0.260+0.198
5Y0.26010Y0.2600.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5300.429+0.101
TTM0.4580.413+0.045
YOY0.3290.391-0.062
5Y0.2600.393-0.133
10Y0.2600.397-0.137
1.4.2. Debt to Equity Ratio

Measures if Pharmacielo is able to pay off its debts by using shareholders equity (total assets - total liabilities).

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 112.9% means that company has $1.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pharmacielo Ltd:

  • The MRQ is 1.129. The company is able to pay all its debts with equity. +1
  • The TTM is 0.861. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.129TTM0.861+0.268
TTM0.861YOY0.537+0.324
TTM0.8615Y0.429+0.432
5Y0.42910Y0.4290.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1290.696+0.433
TTM0.8610.678+0.183
YOY0.5370.624-0.087
5Y0.4290.681-0.252
10Y0.4290.691-0.262

2. Market Valuation of Pharmacielo Ltd

2. Earnings
2.1. Price to Earnings Ratio
  • Compares the company's stock price to its earnings.
  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 15 means the investor is paying $15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pharmacielo Ltd:

  • The EOD is -2.402. Company is losing money. -2
  • The MRQ is -2.589. Company is losing money. -2
  • The TTM is -3.496. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-2.402MRQ-2.589+0.188
MRQ-2.589TTM-3.496+0.907
TTM-3.496YOY-3.229-0.267
TTM-3.4965Y-3.744+0.248
5Y-3.74410Y-3.7440.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-2.4020.331-2.733
MRQ-2.5890.392-2.981
TTM-3.4961.363-4.859
YOY-3.2293.640-6.869
5Y-3.7446.176-9.920
10Y-3.7446.668-10.412
2.2. Price Earnings to Growth Ratio
  • Measures how expensive or cheap the stock is compared to its predicted growth
  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Pharmacielo Ltd:

  • The MRQ is 0.043. Very good. +2
  • The TTM is 0.120. Very good. +2
Trends
Current periodCompared to+/- 
MRQ0.043TTM0.120-0.077
TTM0.120YOY-1.707+1.827
TTM0.1205Y-0.793+0.913
5Y-0.79310Y-0.7930.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0430.003+0.040
TTM0.1200.019+0.101
YOY-1.7070.032-1.739
5Y-0.7930.025-0.818
10Y-0.7930.026-0.819

2. Books
2.3. Price to Book Ratio
  • Shows if the stock is under or overvalued compared to it's book value (total assets - total liabilities).
  • At or below 1 is considered healthy
  • A PB ratio of 3 means the investor is paying $3 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pharmacielo Ltd:

  • The EOD is 3.312. Neutral. Compare to industry.
  • The MRQ is 3.571. Neutral. Compare to industry.
  • The TTM is 5.265. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.312MRQ3.571-0.259
MRQ3.571TTM5.265-1.694
TTM5.265YOY6.200-0.935
TTM5.2655Y3.601+1.664
5Y3.60110Y3.6010.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD3.3121.392+1.920
MRQ3.5711.617+1.954
TTM5.2652.042+3.223
YOY6.2002.268+3.932
5Y3.6011.997+1.604
10Y3.6011.517+2.084

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pharmacielo Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0940.124-25%0.211-56%0.168-44%0.168-44%
Current Ratio--0.8090.922-12%1.267-36%4.429-82%4.429-82%
Debt To Asset Ratio--0.5300.458+16%0.329+61%0.260+104%0.260+104%
Debt To Equity Ratio--1.1290.861+31%0.537+110%0.429+163%0.429+163%
Eps---0.023-0.032+39%-0.081+246%-0.061+164%-0.061+164%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---1.660-8.566+416%-72.136+4246%-26.045+1469%-26.045+1469%
Operating Margin---1.390-7.834+463%-104.229+7396%-34.065+2350%-34.065+2350%
Operating Ratio--2.99610.849-72%89.123-97%30.888-90%30.888-90%
Pb Ratio3.312-8%3.5715.265-32%6.200-42%3.601-1%3.601-1%
Pe Ratio-2.402+7%-2.589-3.496+35%-3.229+25%-3.744+45%-3.744+45%
Peg Ratio--0.0430.120-64%-1.707+4052%-0.793+1937%-0.793+1937%
Price Per Share0.310-8%0.3340.681-51%1.106-70%1.792-81%1.792-81%
Quick Ratio--1.2030.376+220%0.213+465%1.225-2%1.225-2%
Return On Assets---0.117-0.138+19%-0.256+119%-0.169+45%-0.169+45%
Return On Equity---0.249-0.251+1%-0.410+65%-0.2470%-0.2470%
 EOD+2 -1MRQTTM+10 -5YOY+9 -65Y+7 -810Y+7 -8

3.2. Fundamental Score

Let's check the fundamental score of Pharmacielo Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.402
Price to Book Ratio (EOD)Between0-13.312
Net Profit Margin (MRQ)Greater than0-1.660
Operating Margin (MRQ)Greater than0-1.390
Quick Ratio (MRQ)Greater than11.203
Current Ratio (MRQ)Greater than10.809
Debt to Asset Ratio (MRQ)Less than10.530
Debt to Equity Ratio (MRQ)Less than11.129
Return on Equity (MRQ)Greater than0.15-0.249
Return on Assets (MRQ)Greater than0.05-0.117
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Pharmacielo Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.226
Ma 20Greater thanMa 500.305
Ma 50Greater thanMa 1000.341
Ma 100Greater thanMa 2000.351
OpenGreater thanClose0.300
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets30,110
Total Liabilities15,970
Total Stockholder Equity14,140
 As reported
Total Liabilities 15,970
Total Stockholder Equity+ 14,140
Total Assets = 30,110

Assets

Total Assets30,110
Total Current Assets5,363
Long-term Assets5,363
Total Current Assets
Cash And Cash Equivalents 1,017
Short-term Investments 149
Net Receivables 7,834
Total Current Assets  (as reported)5,363
Total Current Assets  (calculated)9,000
+/- 3,637
Long-term Assets
Property Plant Equipment 23,431
Long Term Investments 1,316
Long-term Assets  (as reported)24,747
Long-term Assets  (calculated)24,747
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,633
Long-term Liabilities9,337
Total Stockholder Equity14,140
Total Current Liabilities
Short Long Term Debt 374
Accounts payable 5,782
Other Current Liabilities 128
Total Current Liabilities  (as reported)6,633
Total Current Liabilities  (calculated)6,284
+/- 350
Long-term Liabilities
Long term Debt 9,163
Capital Lease Obligations Min Short Term Debt439
Other Liabilities 0
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)9,337
Long-term Liabilities  (calculated)9,602
+/- 265
Total Stockholder Equity
Common Stock158,382
Retained Earnings -174,327
Other Stockholders Equity 30,084
Total Stockholder Equity (as reported)14,140
Total Stockholder Equity (calculated)14,140
+/-0
Other
Capital Stock158,382
Common Stock Shares Outstanding 151,162
Net Debt 8,520
Net Invested Capital 23,678
Net Tangible Assets 14,140
Net Working Capital -1,270



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
> Total Assets 
48,573
64,590
58,596
55,553
50,196
42,375
47,707
43,087
44,024
36,807
43,001
37,277
35,957
33,089
30,110
30,11033,08935,95737,27743,00136,80744,02443,08747,70742,37550,19655,55358,59664,59048,573
   > Total Current Assets 
34,269
42,003
34,521
29,576
19,672
13,223
13,101
7,832
12,518
7,693
14,283
9,064
9,197
6,078
5,363
5,3636,0789,1979,06414,2837,69312,5187,83213,10113,22319,67229,57634,52142,00334,269
       Cash And Cash Equivalents 
5,388
24,572
17,022
4,461
13,673
6,040
5,068
3,242
8,860
4,004
11,022
6,033
5,338
1,420
1,017
1,0171,4205,3386,03311,0224,0048,8603,2425,0686,04013,6734,46117,02224,5725,388
       Short-term Investments 
270
16,608
16,443
16,338
106
58
322
92
750
1,216
619
420
291
238
149
1492382914206191,216750923225810616,33816,44316,608270
       Net Receivables 
0
0
0
3,826
1,822
1,952
2,233
1,105
924
1,328
1,412
774
277
570
7,834
7,8345702777741,4121,3289241,1052,2331,9521,8223,826000
       Inventory 
62
132
245
3,712
3,466
4,091
4,454
2,565
1,253
873
1,181
1,370
2,281
2,627
2,293
2,2932,6272,2811,3701,1818731,2532,5654,4544,0913,4663,71224513262
       Other Current Assets 
28,093
0
0
1,046
179
119
479
39
0
0
0
0
0
-20
0
0-2000000394791191791,0460028,093
   > Long-term Assets 
0
22,587
24,076
25,978
30,524
28,944
34,606
31,573
31,506
29,114
28,717
28,214
26,760
27,010
24,747
24,74727,01026,76028,21428,71729,11431,50631,57334,60628,94430,52425,97824,07622,5870
       Property Plant Equipment 
14,304
22,587
24,076
24,703
28,721
26,864
30,443
28,183
30,820
28,425
27,838
27,415
26,120
25,939
23,431
23,43125,93926,12027,41527,83828,42530,82028,18330,44326,86428,72124,70324,07622,58714,304
       Goodwill 
0
0
0
860
1,163
1,049
1,085
1,031
0
0
0
0
0
0
0
00000001,0311,0851,0491,163860000
       Long Term Investments 
0
0
0
0
0
500
2,566
2,017
565
650
880
798
640
1,072
1,316
1,3161,0726407988806505652,0172,56650000000
       Intangible Assets 
0
0
0
415
640
531
440
341
120
0
0
0
0
0
0
000000120341440531640415000
       Other Assets 
0
0
0
0
0
570
72
0
0
0
0
0
0
0
0
000000007257000000
> Total Liabilities 
2,213
3,570
6,540
7,459
4,731
5,982
7,737
5,759
17,777
16,732
13,998
14,296
16,631
15,030
15,970
15,97015,03016,63114,29613,99816,73217,7775,7597,7375,9824,7317,4596,5403,5702,213
   > Total Current Liabilities 
2,213
2,247
4,688
5,681
3,306
5,111
5,460
4,100
12,057
12,061
9,635
9,989
8,072
7,293
6,633
6,6337,2938,0729,9899,63512,06112,0574,1005,4605,1113,3065,6814,6882,2472,213
       Short-term Debt 
0
120
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001200
       Short Long Term Debt 
0
120
0
0
0
0
0
0
93
107
82
83
79
62
374
37462798382107930000001200
       Accounts payable 
2,213
2,127
1,703
2,231
2,900
4,868
5,205
3,844
9,108
9,100
8,796
9,647
7,733
6,860
5,782
5,7826,8607,7339,6478,7969,1009,1083,8445,2054,8682,9002,2311,7032,1272,213
       Other Current Liabilities 
0
120
2,855
3,321
258
98
98
97
0
0
0
0
0
0
128
1280000009798982583,3212,8551200
   > Long-term Liabilities 
0
1,323
1,853
1,778
1,425
1,353
2,277
1,659
5,721
4,671
4,363
4,307
8,559
7,737
9,337
9,3377,7378,5594,3074,3634,6715,7211,6592,2771,3531,4251,7781,8531,3230
       Other Liabilities 
0
0
560
526
0
1,072
974
406
1,491
689
564
439
356
0
0
003564395646891,4914069741,072052656000
> Total Stockholder Equity
46,359
61,017
52,052
47,964
45,465
36,394
39,970
37,328
26,247
20,075
29,003
22,982
19,326
18,059
14,140
14,14018,05919,32622,98229,00320,07526,24737,32839,97036,39445,46547,96452,05261,01746,359
   Common Stock
50,876
106,534
107,940
109,412
116,828
117,280
125,678
130,933
138,082
140,107
153,676
156,307
156,338
157,845
158,382
158,382157,845156,338156,307153,676140,107138,082130,933125,678117,280116,828109,412107,940106,53450,876
   Retained Earnings -174,327-170,810-167,898-163,785-155,035-147,810-141,268-121,345-111,550-103,831-97,513-85,089-81,269-70,584-49,311
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
44,794
25,067
25,382
23,642
26,150
23,884
25,843
24,057
29,433
27,779
30,361
30,460
30,886
31,024
30,084
30,08431,02430,88630,46030,36127,77929,43324,05725,84323,88426,15023,64225,38225,06744,794



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue1,945
Cost of Revenue-6,253
Gross Profit-4,308-4,308
 
Operating Income (+$)
Gross Profit-4,308
Operating Expense-27,139
Operating Income-25,194-31,447
 
Operating Expense (+$)
Research Development-
Selling General Administrative19,149
Selling And Marketing Expenses-
Operating Expense27,13919,149
 
Net Interest Income (+$)
Interest Income2
Interest Expense-561
Net Interest Income-559-559
 
Pretax Income (+$)
Operating Income-25,194
Net Interest Income-559
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-26,630-24,317
EBIT - interestExpense = -25,618
-26,630
-26,068
Interest Expense561
Earnings Before Interest and Taxes (ebit)-25,057-26,068
Earnings Before Interest and Taxes (ebitda)-24,750
 
After tax Income (+$)
Income Before Tax-26,630
Tax Provision--
Net Income From Continuing Ops-26,630-26,630
Net Income-26,630
Net Income Applicable To Common Shares-26,630
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-877559
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
USO.MX
3 minutes ago

I found you a Death Cross on the daily chart of USO.MX.

USO.MX Daily Candlestick Chart
ATMS.PINK
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ATMS.PINK.

ATMS.PINK Daily Candlestick Chart
CTM.V
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CTM.V.

CTM.V Daily Candlestick Chart
USLG.PINK
9 minutes ago

I found you a Death Cross on the daily chart of USLG.PINK.

USLG.PINK Daily Candlestick Chart
FTWIJPNC.INDX
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FTWIJPNC.INDX.

FTWIJPNC.INDX Daily Candlestick Chart
0IZ8.IL
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0IZ8.IL.

0IZ8.IL Daily Candlestick Chart
0IT3.IL
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 0IT3.IL.

0IT3.IL Daily Candlestick Chart
RY4C.STU
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of RY4C.STU.

RY4C.STU Daily Candlestick Chart
TDSA.LS
17 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TDSA.LS.

TDSA.LS Daily Candlestick Chart
RAM.LS
19 minutes ago

I found you a Golden Cross on the daily chart of RAM.LS.

RAM.LS Daily Candlestick Chart
PHR.LS
19 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PHR.LS.

PHR.LS Daily Candlestick Chart
UQA.VI
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UQA.VI.

UQA.VI Daily Candlestick Chart
CAV.WAR
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CAV.WAR.

CAV.WAR Daily Candlestick Chart
FOR.V
23 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of FOR.V.

FOR.V Daily Candlestick Chart
CVD.TO
25 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CVD.TO.

CVD.TO Daily Candlestick Chart
HOT-U.TO
25 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of HOT-U.TO.

HOT-U.TO Daily Candlestick Chart
SBSAA.PINK
27 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SBSAA.PINK.

SBSAA.PINK Daily Candlestick Chart
MGY.NYSE
27 minutes ago

I found you a Death Cross on the daily chart of MGY.NYSE.

MGY.NYSE Daily Candlestick Chart
MCS.NYSE
29 minutes ago

I found you a Death Cross on the daily chart of MCS.NYSE.

MCS.NYSE Daily Candlestick Chart
MCFT.NASDAQ
29 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of MCFT.NASDAQ.

MCFT.NASDAQ Daily Candlestick Chart
MBIN.NASDAQ
29 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MBIN.NASDAQ.

MBIN.NASDAQ Daily Candlestick Chart
LYLT.NASDAQ
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LYLT.NASDAQ.

LYLT.NASDAQ Daily Candlestick Chart
LSF.NYSE MKT
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LSF.NYSE MKT.

LSF.NYSE MKT Daily Candlestick Chart
LRN.NYSE
31 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LRN.NYSE.

LRN.NYSE Daily Candlestick Chart
NESN.VX
31 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NESN.VX.

NESN.VX Daily Candlestick Chart